KRUS:NASDAQKura Sushi USA, Inc. Analysis
Data as of 2026-04-13 - not real-time
$55.66
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Kura Sushi USA (KRUS) is trading at $55.66, well beneath its 20‑day, 50‑day and 200‑day simple moving averages of $63.0, $66.3 and $67.2, signaling a clear bearish price trend. The 14‑day RSI sits at 38, edging toward oversold territory but not yet indicating a reversal. MACD remains in a bearish configuration, with the line at –1.22 below the signal at –0.18 and a negative histogram, reinforcing downside momentum. Volatility is extreme, with a 30‑day standard deviation of roughly 86% and a beta above 1, suggesting the stock will move sharply on new information. On the fundamentals side, revenue grew 23% year‑over‑year to $307 M, yet gross margin is only 16% and the company posted a net loss of $0.15 per share. Debt is high, with a debt‑to‑equity ratio near 89% and total liabilities outstripping cash on hand.
Operating cash flow is positive at $24 M, but free cash flow is deeply negative (‑$36 M), highlighting cash‑generation pressure. The discounted cash‑flow model values the business at $35.7 per share, implying a downside of roughly 43% from the current price. Analysts remain optimistic, assigning a “buy” consensus and a median price target near $80, but the market sentiment index is in “Extreme Greed” territory, which may be inflating the price. Recent material news showed a 15.7% intraday drop after the company issued a conservative full‑year outlook and announced a CFO transition, despite a Q2 earnings beat. The combination of high leverage, negative profitability, and bearish technical signals makes the near‑term outlook risky. However, the strong revenue growth and positive operating cash flow provide a foundation for a potential turnaround if margins improve and debt is reduced.
Operating cash flow is positive at $24 M, but free cash flow is deeply negative (‑$36 M), highlighting cash‑generation pressure. The discounted cash‑flow model values the business at $35.7 per share, implying a downside of roughly 43% from the current price. Analysts remain optimistic, assigning a “buy” consensus and a median price target near $80, but the market sentiment index is in “Extreme Greed” territory, which may be inflating the price. Recent material news showed a 15.7% intraday drop after the company issued a conservative full‑year outlook and announced a CFO transition, despite a Q2 earnings beat. The combination of high leverage, negative profitability, and bearish technical signals makes the near‑term outlook risky. However, the strong revenue growth and positive operating cash flow provide a foundation for a potential turnaround if margins improve and debt is reduced.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Conservative guidance and CFO turnover depress sentiment
- Price below all major moving averages and bearish MACD
- High volatility and downside relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Revenue growth of >20% and positive operating cash flow
- Analyst consensus remains bullish with $80 price target
- Debt reduction and margin improvement needed but plausible
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential for operational turnaround and cash‑flow conversion
- Persistent high leverage and negative free cash flow limit upside
- Valuation still above DCF, requiring significant earnings improvement
Key Metrics & Analysis
Financial Health
Revenue Growth23.30%
Profit Margin-0.63%
P/E Ratio196.1
ROE-0.85%
ROA-0.42%
Debt/Equity88.79
P/B Ratio2.9
Op. Cash Flow$24.2M
Free Cash Flow$-36375124
Technical Analysis
TrendBearish
RSI37.8
Support$53.58
Resistance$74.81
MA 20$63.04
MA 50$66.34
MA 200$67.25
MACDBearish
VolumeIncreasing
Fear & Greed Index87.29
Valuation
Fair Value$35.67
Target Price$79.90
Upside/Downside43.55%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.12
Volatility85.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.